OPA1 in Cardiovascular Health and Disease

Author(s): Niall Burke, Andrew R. Hall, Derek J. Hausenloy

Journal Name: Current Drug Targets

Volume 16 , Issue 8 , 2015

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Mitochondria are known to play crucial roles in normal cellular physiology and in more recent years they have been implicated in a wide range of pathologies. Central to both these roles is their ability to alter their shape interchangeably between two different morphologies: an elongated interconnected network and a fragmented discrete phenotype - processes which are under the regulation of the mitochondrial fusion and fission proteins, respectively. In this review article, we focus on the mitochondrial fusion protein optic atrophy protein 1 (OPA1) in cardiovascular health and disease and we explore its role as a potential therapeutic target for treating cardiovascular and metabolic disease.

Keywords: Cardiovascular disease, fission, fusion, mitochondrial morphology, OPA1.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 01 January, 2015
Page: [912 - 920]
Pages: 9
DOI: 10.2174/1389450116666150102113648
Price: $65

Article Metrics

PDF: 32